Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Pharmacologic potential of new nitro-compounds as antimicrobial agents against nosocomial pathogens: design, synthesis, and in vitro effectiveness.

Andrade JT, Alves SLG, Lima WG, Sousa CDF, Carmo LF, De Sá NP, Morais FB, Johann S, Villar JAFP, Ferreira JMS.

Folia Microbiol (Praha). 2019 Aug 10. doi: 10.1007/s12223-019-00747-7. [Epub ahead of print]

PMID:
31401762
2.

21‑Benzylidene digoxin, a novel digoxin hemi-synthetic derivative, presents an anti-inflammatory activity through inhibition of edema, tumour necrosis factor alpha production, inducible nitric oxide synthase expression and leucocyte migration.

Vieira L, Saldanha AA, Moraes AM, Oliveira FM, Lopes DO, Barbosa LAO, Ribeiro RIMA, Thomé RG, Santos HBD, Villar JAFP, Soares AC.

Int Immunopharmacol. 2018 Dec;65:174-181. doi: 10.1016/j.intimp.2018.10.010. Epub 2018 Oct 10.

PMID:
30316075
3.

Rational selection of immunodominant and preserved epitope Sm043300e from Schistosoma mansoni and design of a chimeric molecule for biotechnological purposes.

de Souza C, Lopes MD, De Oliveira FM, Passos MJF, Ferreira LCG, Faria BF, Villar JAFP, Junior MC, Taranto AG, Dos Santos LL, Fonseca CT, de Oliveira Lopes D.

Mol Immunol. 2018 Jan;93:133-143. doi: 10.1016/j.molimm.2017.11.019. Epub 2017 Nov 22.

PMID:
29175593
4.

Synthesis and biological evaluation of novel 3-alkylpyridine marine alkaloid analogs with promising anticancer activity.

Gonçalves AM, de Lima AB, da Silva Barbosa MC, de Camargos LF, de Oliveira JT, de Souza Barbosa C, Villar JA, Costa AC, Silva IV, Silva LM, de Pilla Varotti F, dos Santos FV, Viana GH.

Mar Drugs. 2014 Jul 31;12(8):4361-78. doi: 10.3390/md12084361.

Supplemental Content

Loading ...
Support Center